Capricorn Fund Managers Ltd Sells 68,827 Shares of Phibro Animal Health Corporation $PAHC

Capricorn Fund Managers Ltd decreased its stake in shares of Phibro Animal Health Corporation (NASDAQ:PAHC) by 27.2% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 184,101 shares of the company’s stock after selling 68,827 shares during the quarter. Phibro Animal Health comprises about 1.7% of Capricorn Fund Managers Ltd’s portfolio, making the stock its 22nd biggest holding. Capricorn Fund Managers Ltd owned about 0.45% of Phibro Animal Health worth $6,878,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently made changes to their positions in the stock. Hughes Financial Services LLC bought a new stake in Phibro Animal Health during the third quarter worth $40,000. iSAM Funds UK Ltd bought a new position in shares of Phibro Animal Health in the 3rd quarter valued at about $61,000. Advisory Services Network LLC acquired a new position in shares of Phibro Animal Health during the 3rd quarter worth about $96,000. EverSource Wealth Advisors LLC raised its holdings in shares of Phibro Animal Health by 7,671.4% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,720 shares of the company’s stock valued at $69,000 after purchasing an additional 2,685 shares during the period. Finally, Spire Wealth Management acquired a new stake in Phibro Animal Health in the 4th quarter valued at about $146,000. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Price Performance

Shares of PAHC opened at $55.52 on Monday. The firm has a market cap of $2.25 billion, a P/E ratio of 24.68, a price-to-earnings-growth ratio of 0.85 and a beta of 0.69. The company has a debt-to-equity ratio of 2.14, a quick ratio of 1.22 and a current ratio of 3.05. Phibro Animal Health Corporation has a 52 week low of $16.16 and a 52 week high of $57.62. The firm’s 50-day simple moving average is $50.46 and its 200 day simple moving average is $43.89.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $0.87 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.18. Phibro Animal Health had a return on equity of 38.28% and a net margin of 6.29%.The company had revenue of $373.91 million during the quarter, compared to analysts’ expectations of $355.64 million. Phibro Animal Health has set its FY 2026 guidance at 2.930-3.100 EPS. On average, analysts forecast that Phibro Animal Health Corporation will post 1.95 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 25th. Shareholders of record on Wednesday, March 4th were given a dividend of $0.12 per share. The ex-dividend date was Wednesday, March 4th. This represents a $0.48 annualized dividend and a yield of 0.9%. Phibro Animal Health’s dividend payout ratio (DPR) is presently 21.33%.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on PAHC. Zacks Research upgraded Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a report on Wednesday, March 11th. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Phibro Animal Health in a research report on Monday, December 29th. Finally, Morgan Stanley set a $49.00 target price on Phibro Animal Health in a research note on Friday, February 6th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $37.50.

Insiders Place Their Bets

In other news, CEO Jack Bendheim sold 110,842 shares of Phibro Animal Health stock in a transaction on Thursday, February 5th. The stock was sold at an average price of $48.38, for a total transaction of $5,362,535.96. Following the completion of the sale, the chief executive officer owned 122,958 shares of the company’s stock, valued at approximately $5,948,708.04. This trade represents a 47.41% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In the last quarter, insiders sold 316,800 shares of company stock worth $15,278,569. 50.13% of the stock is owned by company insiders.

About Phibro Animal Health

Phibro Animal Health Corporation (NASDAQ: PAHC) is a diversified global animal health and mineral nutrition company headquartered in Teaneck, New Jersey. The company develops, manufactures and markets a broad range of pharmaceutical, mineral nutrition and performance products designed to support the health and productivity of livestock, companion animals and aquaculture species. Phibro’s portfolio includes vaccines, anti-infective therapies, coccidiostats, disinfectants, premix minerals and specialty feed additives aimed at enhancing growth, immunity and overall animal well-being.

The company operates through three principal business segments: Animal Health, Mineral Nutrition and Performance Products.